Early non-cancer mortality risk prediction after curative-intent radiotherapy or chemoradiotherapy for head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

Early non-cancer mortality risk prediction after curative-intent radiotherapy or chemoradiotherapy for head and neck squamous cell carcinoma

Published:2022-06 Issue: Volume:171 Page:1-6
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Jensen Kristian Hastoft,Vogelius Ivan Richter,Bernsdorf Mogens,Gothelf Anita,Kristensen Claus Andrup,Maare Christian,Andersen Elo,Specht Lena,Friborg Jeppe

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference45 articles.

1. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial;Nutting;Lancet Oncol,2011

2. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients;Pignon;Radiother Oncol,2009

3. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85;Overgaard;Radiother Oncol,1998

4. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial;Overgaard;Lancet,2003

5. Radiation oncology in the era of precision medicine;Baumann;Nat Rev Cancer,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in vaccination uptake against pneumococcal disease, influenza, and coronavirus disease 2019 (COVID-19) before and after a Head and Neck cancer diagnosis;Vaccine;2024-08

2. Six-month mortality has decreased for patients with curative treatment intent for head and neck cancer in Sweden;PLOS ONE;2024-04-16

3. Six-month mortality has decreased for patients with curative treatment for head and neck cancer in Sweden;2023-12-17